You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

Details for Patent: 10,792,262

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,792,262 protect, and when does it expire?

Patent 10,792,262 protects LYVISPAH and is included in one NDA.

This patent has nine patent family members in eight countries.

Summary for Patent: 10,792,262

Scope and claims summary:

Title:	Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
Abstract:	Pharmaceutical compositions including an active ingredient and a stabilizer, as well as methods of manufacture of the compositions, and methods of their use.
Inventor(s):	Penake; David (Atlanta, GA), Hamm; Sharon (Odessa, FL), O'Mahony; Leonard (Westmeath, IE), Devane; John (Dublin, IE), Mohr; Wolfgang (Freiburg, DE), Weinheimer; Manuel (Neuenburg am Rhein, DE)
Assignee:	SAOL INTERNATIONAL LIMITED (Hamilton, BM)
Application Number:	16/524,664
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 10,792,262

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Amneal	LYVISPAH	baclofen	GRANULES;ORAL	215422-001	Nov 22, 2021		RX	Yes	No	⤷ Subscribe	⤷ Subscribe	Y			METHOD FOR TREATING SPASTICITY	⤷ Subscribe
Amneal	LYVISPAH	baclofen	GRANULES;ORAL	215422-002	Nov 22, 2021		RX	Yes	No	⤷ Subscribe	⤷ Subscribe	Y			METHOD FOR TREATING SPASTICITY	⤷ Subscribe
Amneal	LYVISPAH	baclofen	GRANULES;ORAL	215422-003	Nov 22, 2021		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe	Y			METHOD FOR TREATING SPASTICITY	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 10,792,262

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2020323846	⤷ Subscribe
Brazil	112022001591	⤷ Subscribe
Canada	3148812	⤷ Subscribe
China	114450002	⤷ Subscribe
European Patent Office	4003323	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.